Patients' physiological reactions to competitive rehabilitation therapies assisted by robotic devices.

Journal Information

Full Title: J Neuroeng Rehabil

Abbreviation: J Neuroeng Rehabil

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physical and Rehabilitation Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe protocol of this study (registration number HLP_35/2021) complies with the Research Ethics Committee of the Hospital La Pedrera of Denia, Spain. Moreover, informed consent was obtained from all subjects involved in the study. Competing interestsN.G.A. is founder of Innovative Devices for Rehabilitation and Assistance (iDRhA) while J.M.C. is CEO of iDRhA. The IP protecting the Rubidium technology is licensed to iDRhA. Competing interests N.G.A. is founder of Innovative Devices for Rehabilitation and Assistance (iDRhA) while J.M.C. is CEO of iDRhA. The IP protecting the Rubidium technology is licensed to iDRhA."

Evidence found in paper:

"Funding This study was supported by the Ministry of Universities and European Union, “financed by European Union - Next Generation EU” through Margarita Salas grant for the training of young doctors; by the Youth Guarantee Plan through the grant EDGJID/2021/075; by the Spanish Ministry of Universities through the grant FPU20/05137; by the Research Grants of the Miguel Hernández University of Elche through the grant 2022/PER/00002; and by the Spanish Ministry of Science and Innovation, through the project PID2019-108310RB-I00 and TED2021-130431B-I00/AEI/10.13039/501100011033/ Unión Europea NextGenerationEU/PRTR."

Evidence found in paper:

"Declarations: Ethics approval and consent to participateThe protocol of this study (registration number HLP_35/2021) complies with the Research Ethics Committee of the Hospital La Pedrera of Denia, Spain. Moreover, informed consent was obtained from all subjects involved in the study.: Competing interestsN.G.A. is founder of Innovative Devices for Rehabilitation and Assistance (iDRhA) while J.M.C. is CEO of iDRhA. The IP protecting the Rubidium technology is licensed to iDRhA. Ethics approval and consent to participate: The protocol of this study (registration number HLP_35/2021) complies with the Research Ethics Committee of the Hospital La Pedrera of Denia, Spain. Moreover, informed consent was obtained from all subjects involved in the study."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025